JIVI (antihemophilic factor (FVIII) rec, B-domain deleted peg-aucl)
ANTIHEMOPHILIC PRODUCTS · HEMOPHILIA A ·+2
Bayer HealthCare
Drug class
Antihemophilic Products
Antihemophilic products are a class of therapeutic biologics comprising plasma-derived and recombinant coagulation factor VIII concentrates, as well as extended half-life factor variants. Read more about Antihemophilic Products
33 drugs in this class 14 manufacturers
Drugs in Antihemophilic Products
ESPEROCT (antihemophilic factor (FVIII) rec, B-dom truncated peg-exei)
ANTIHEMOPHILIC PRODUCTS · HEMOPHILIA A ·+2
NOVO NORDISK
HUMATE-P (antihemophilic factor, human/von Willebrand factor,human)
ANTIHEMOPHILIC PRODUCTS · HEMOPHILIA A ·+6
CSL Behring
AFSTYLA (antihemophilic factor VIII recomb,single-chn,B-dom truncated)
ANTIHEMOPHILIC PRODUCTS · HEMOPHILIA A ·+2
CSL Behring
HEMOFIL M MID (antihemophilic factor, human)
ANTIHEMOPHILIC PRODUCTS · HEMOPHILIA A ·+2
BAXALTA US INC.
HEMOFIL M HIGH (antihemophilic factor, human)
ANTIHEMOPHILIC PRODUCTS · HEMOPHILIA A ·+2
BAXALTA US INC.
HEMOFIL M SUPER HIGH (antihemophilic factor, human)
ANTIHEMOPHILIC PRODUCTS · HEMOPHILIA A ·+2
BAXALTA US INC.
HEMOFIL M LOW (antihemophilic factor, human)
ANTIHEMOPHILIC PRODUCTS · HEMOPHILIA A ·+2
BAXALTA US INC.
ALTUVIIIO (antihemophilic factor rFVIII Fc-VWF-XTEN,BDD-ehtl)
ANTIHEMOPHILIC PRODUCTS · HEMOPHILIA A ·+2
BIOVERATIV THER
Filter & compare in the drug finder →
Opens the drug finder with Antihemophilic Products preselected. Add indication or manufacturer filters there.
Antihemophilic products are a class of therapeutic biologics comprising plasma-derived and recombinant coagulation factor VIII concentrates, as well as extended half-life factor variants.
They function primarily through factor replacement therapy, substituting for missing or dysfunctional endogenous factor VIII to serve as an essential cofactor in activating factor X within the intrinsic coagulation cascade and restoring effective hemostasis.
These agents are indicated primarily for the on-demand control of bleeding, routine prophylaxis, and perioperative management in individuals with hemophilia A, with certain plasma-derived formulations also indicated for select types of von Willebrand disease.
-
fda.gov
Antihemophilic products are a class of therapeutic biologics comprising plasma-derived and recombinant coagulation factor VIII concentrates, as well as extended half-life factor variants
-
nih.gov
Antihemophilic products are a class of therapeutic biologics comprising plasma-derived and recombinant coagulation factor VIII concentrates, as well as extended half-life factor variants
-
drugbank.com
They function primarily through factor replacement therapy, substituting for missing or dysfunctional endogenous factor VIII to serve as an essential cofactor in activating factor X within the intrinsic coagulation cascade and restoring effective hemostasis
-
fda.gov
These agents are indicated primarily for the on-demand control of bleeding, routine prophylaxis, and perioperative management in individuals with hemophilia A, with certain plasma-derived formulations also indicated for select types of von Willebrand disease
-
fda.gov
These agents are indicated primarily for the on-demand control of bleeding, routine prophylaxis, and perioperative management in individuals with hemophilia A, with certain plasma-derived formulations also indicated for select types of von Willebrand disease
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.